Detailed Findings

Spotting the Risks

0%

After a year, geopolitical risk has leapt up the agenda – with 40% highlighting it as the greatest risk, up from 26% last year. Both Institutional Investors and Private Equity are worried about it in equal measure – and with Corporates (44%) most worried of all. 

Funding and pricing cuts continue to be a concern, and were a narrow second choice by respondents as the greatest risk to the sector. 36% selected it, up from 33% who were worried about a lack of funding last year. Private Equity is particularly bearish on funding and pricing cuts, with 55% selecting it. 

Interestingly, only 2% see cybersecurity as the biggest risk. 

What do you believe to be the GREATEST risk to the Healthcare sector in 2025?

What do you believe to be the GREATEST risk to the Healthcare sector in 2025?
All (2024)Institutional InvestorPrivate Equity InvestorHealthcare Corporate Representative
Geopolitical40303144
Cybersecurity2031
Regulatory101669
Funding or price cuts36345532
Patient access4434
Lack of innovation41123
Other3204
There are no significant risks2402

IMPORTANT: You must read the following before reading, accessing or making any other use of this publication. In accessing this publication, you agree to be bound by the following terms and conditions. This document is being furnished for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase any security or other financial instrument or product. It is not intended to form the basis of any investment decision. Jefferies International Limited and its affiliates (together “Jefferies”) makes no representation as to the accuracy or completeness of the information contained herein or any other information, whether written or oral, made available. Jefferies disclaims all and any liability whatsoever, whether arising in tort, contract or otherwise, for the contents of this publication. You acknowledge that Jefferies does not owe you or any other person or entity, any fiduciary or similar duty as a result of the publication of this report, and Jefferies is not providing any advice, including with respect to legal, tax, accounting, investment or regulatory matters, in any jurisdiction.